The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKennedy Wil. 25 Regulatory News (61NM)

Share Price Information for Kennedy Wil. 25 (61NM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 79.652
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 79.652
61NM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

11 Nov 2022 08:32

RNS Number : 1216G
Kennedy Wilson Europe Real Estate
11 November 2022
 

Kennedy Wilson Europe Real Estate Limited Announces Results of its Tender Offer in respect of its EUR550,000,000 3.250 per cent. Notes due 2025

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (EUWA).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the United States) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (the Securities Act)) OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

11 November 2022. Kennedy Wilson Europe Real Estate Limited (the Offeror) announces today the results of its invitation to holders of its EUR550,000,000 3.250 per cent. Notes due 2025 (ISIN: XS1321149434) (the Notes) to tender their Notes for purchase by the Offeror for cash (the Offer).

The Offer was announced on 4 November 2022, and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 4 November 2022 (the Tender Offer Memorandum) prepared by the Offeror. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offer was 5.00 p.m. (CET) on 10 November 2022, with the Offeror having the discretion to accept for purchase any Notes tendered after such time.

A total of EUR75,000,000 in aggregate nominal amount of the Notes has been validly tendered for purchase pursuant to the Offer. 

The Offeror announces that it has decided to set the Final Acceptance Amount at EUR75,000,000 in aggregate nominal amount of Notes. Accordingly, the Offeror will accept for purchase all Notes validly tendered pursuant to the Offer with no pro rata scaling. Notes that have not been successfully tendered or accepted for purchase pursuant to the Offer will remain outstanding.

A summary of the results of the Offer appears below:

Description of the Notes

ISIN / Common Code

Final Acceptance Amount

Scaling Factor

Purchase Price

EUR550,000,000 3.250 per cent. Notes due 2025

XS1321149434 / 132114943

EUR75,000,000

N/A

82 per cent.

The Settlement Date in respect of those Notes accepted for purchase is expected to be 16 November 2022. Following settlement of the Offer, EUR475,000,000 in aggregate nominal amount of the Notes will remain outstanding.

J.P. Morgan Securities plc (Telephone: +44 20 7134 2468; Attention: Liability Management; Email: liability_management_EMEA@jpmorgan.com) is acting as Dealer Manager for the Offer and Kroll Issuer Services Limited (Telephone: +44 20 7704 0880; Attention: Thomas Choquet; Email: kennedywilson@is.kroll.com; Offer Website: https://deals.is.kroll.com/kennedywilson) is acting as Tender Agent.

This announcement is released by the Offeror and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of United Kingdom domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the Offer described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Padmini Singla, General Counsel, Europe of the Offeror.

LEI Number: 213800WIL553Z1T6DZ52

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement.  The distribution of this announcement and/or the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Offeror, the Dealer Manager and the Tender Agent to inform themselves about, and to observe, any such restrictions. The Offer has now expired.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEEAPFFFDFAFEA
Date   Source Headline
26th Apr 20248:00 amRNSAUDITED 2023 IFRS Financial Statements
29th Aug 20238:00 amRNSUnaudited IFRS financial statements
27th Apr 20238:00 amRNSAUDITED 2022 IFRS Financial Statements
11th Nov 20228:32 amRNSResult of Tender Offer
4th Nov 20227:45 amRNSTender Offer
16th Aug 20228:00 amRNSPublication of unaudited IFRS financial statements
25th Apr 20228:00 amRNSAUDITED 2021 IFRS Financial Statements
11th Oct 20217:00 amRNSNOTICE OF EARLY REDEMPTION
7th Oct 202111:37 amRNSNOTICE OF MAKE WHOLE REDEMPTION PRICE
8th Sep 20217:00 amRNSNOTICE OF AMENDMENT TO EARLY REDEMPTION
24th Aug 20218:30 amRNSUnaudited H1 2021 IFRS financial statements
10th Aug 20217:00 amRNSNOTICE OF EARLY REDEMPTION
30th Apr 20218:30 amRNSAUDITED 2020 IFRS Financial Statements
26th Apr 20219:00 amRNSNotice of Partial Redemption
22nd Apr 202112:12 pmRNSNotice of Make Whole Redemption Price
25th Mar 20217:00 amRNSNotice of Partial Redemption
15th Oct 20209:00 amRNSResults of Tender Offer
7th Oct 20207:45 amRNSKennedy Wilson Europe Announces Tender Offer
28th Aug 20208:30 amRNSUnaudited H1 2020 IFRS financial statements
30th Apr 20208:00 amRNSAUDITED 2019 IFRS Financial Statements
29th Aug 20199:00 amRNSUnaudited H1 2019 IFRS financial statements
27th Mar 20198:00 amRNSAUDITED 2018 IFRS Financial Statements
20th Aug 20188:00 amRNSUnaudited H1 2018 IFRS financial statements
28th Nov 20177:00 amRNSRe-registration as a private limited company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.